Metastasis of
cancer is the cause of the majority of
cancer deaths. Active compound
flaccidoxide-13-acetate, isolated from the soft coral Cladiella kashmani, has been found to exhibit anti-
tumor activity. In this study, Boyden chamber analysis, Western blotting and
gelatin zymography assays indicated that
flaccidoxide-13-acetate exerted inhibitory effects on the migration and invasion of RT4 and T24 human
bladder cancer cells. The results demonstrated that
flaccidoxide-13-acetate, in a concentration-dependent manner, reduced the levels of
matrix metalloproteinase-2 (MMP-2), MMP-9,
urokinase-type plasminogen activator receptor (uPAR),
focal adhesion kinase (FAK), phosphatidylinositide-3
kinases (PI3K), p-PI3K, AKT, p-AKT,
mammalian target of rapamycin (mTOR), p-mTOR, Ras homolog gene family, member A (Rho A), Ras,
mitogen-activated protein kinase kinase 7 (MKK7) and
mitogen-activated protein kinase kinase kinase 3 (MEKK3), and increased the expressions of
tissue inhibitor of metalloproteinase-1 (TIMP-1) and
TIMP-2 in RT4 and T24 cells. This study revealed that
flaccidoxide-13-acetate suppressed cell migration and invasion by reducing the expressions of MMP-2 and MMP-9, regulated by the FAK/PI3K/AKT/mTOR pathway. In conclusion, our study was the first to demonstrate that
flaccidoxide-13-acetate could be a potent medical agent for use in controlling the migration and invasion of
bladder cancer.